サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1386902

放射線治療の世界市場：タイプ別、技術別、処置別、用途別、エンドユーザー別、地域別 - 予測（～2028年）

Radiotherapy Market by Type, Technology, Procedure, Application, End User & Region - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 277 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
放射線治療の世界市場：タイプ別、技術別、処置別、用途別、エンドユーザー別、地域別 - 予測（～2028年）
出版日: 2023年11月10日
発行: MarketsandMarkets
ページ情報: 英文 277 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

レポートの概要

調査範囲
調査対象年 2021年～2028年
基準年 2022年
予測期間 2023年～2028年
単位 金額（10億米ドル）
セグメント タイプ、技術、用途、処置、エンドユーザー、地域
対象地域 北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカ

世界の放射線治療の市場規模は、2023年に69億米ドル、2028年までに88億米ドルに達し、予測期間にCAGRで5.0％の成長が予測されています。

世界のがん罹患率の上昇、放射線治療技術の進歩、世界のがんセンターでの粒子線治療の採用の拡大が、予測期間に市場の成長を後押しする可能性があります。

「ソフトウェア・サービスセグメントが予測期間にもっとも高いCAGRで成長します。」

ソフトウェア・サービスセグメントは、北米や欧州などの確立された市場で高い成長率を記録すると予測されています。放射線治療の進歩や、より正確で個別化されたがん治療計画への需要の高まりが、革新的な放射線治療ソフトウェア・サービスの開発につながっています。

「技術別では、外部照射放射線治療セグメントが2022年に市場で最大の市場シェアを占めています。」

外部照射放射線治療（EBRT）セグメントは、外部照射放射線治療技術の広範な採用、先進の外部照射放射線治療技術の開発と商業化に向けた市場企業の継続的な研究開発投資により、2022年に放射線治療で最大のシェアを占めました。

「外部照射放射線治療の用途別では、前立腺がんが2022年に最大の市場シェアを占めました。」

前立腺がんは、世界の前立腺がん罹患率の増加、前立腺がんに対する外部照射放射線治療がもたらす利益、前立腺がん治療に向けた放射線治療の分野における研究活動の増加により、2022年に最大の市場シェアを占めました。

地域別では、北米が市場で最大のシェアを占めています。

北米は放射線治療の製品・サービスの最大の地域市場であり、一方でアジア太平洋市場は予測期間にもっとも高いCAGRで成長すると推定されています。北米の最大シェアは、先進の放射線治療技術の急速な採用、放射線治療ソフトウェアメーカーとエンドユーザーの協力の増加、北米各国の医療施設とサービスの多様なネットワークのプレゼンス、地域のがん治療を支える有利な償還モデルに起因しています。

当レポートでは、世界の放射線治療市場について調査分析し、主な促進要因と抑制要因、競合情勢、将来の動向などの情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 放射線治療市場の概要
  • 外部照射放射線治療市場：タイプ別（2023年・2028年）
  • 欧州の外部照射放射線治療市場：技術別、地域別（2022年）
  • 放射線治療市場：地理的な成長機会

第5章 市場の概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • ポーターのファイブフォース分析
  • 規制情勢
    • 北米
    • カナダ
    • 欧州
    • アジア太平洋
    • インド
  • 償還シナリオ
  • エコシステム/市場マップ
  • バリューチェーン分析
    • 研究開発
    • 調達と商品開発
    • マーケティング、販売、流通、販売後サービス
  • サプライチェーン分析
    • 著名企業
    • 中小企業
    • エンドユーザー
  • 貿易データ
  • 価格分析
  • 主な会議とイベント（2023年～2025年）
  • 技術分析
  • 特許分析
  • ケーススタディ分析
  • 顧客のビジネスに影響を与える動向/混乱
  • 主なステークホルダーと購入基準
    • 購入プロセスにおける主なステークホルダー
    • 購入基準

第6章 放射線治療市場：製品・サービス別

  • イントロダクション
  • 製品
  • ソフトウェア・サービス

第7章 放射線治療市場：技術別

  • イントロダクション
  • 外部照射放射線治療
  • リニアック
  • 粒子線治療
  • 従来のコバルト60遠隔療法
  • 内部照射放射線治療/近接照射療法
  • シード
  • アフターローダー
  • IORTシステム
  • アプリケーター
  • 全身性放射線治療

第8章 放射線治療市場：用途別

  • イントロダクション
  • 外部照射放射線治療の用途
    • 前立腺がん
    • 乳がん
    • 肺がん
    • 頭頸部がん
    • 大腸がん
    • その他の外部照射放射線治療の用途
  • 内部照射放射線治療/近接照射療法の用途
    • 前立腺がん
    • 婦人科がん
    • 乳がん
    • 子宮頸がん
    • 陰茎がん
    • その他の内部照射放射線治療/近接照射療法の用途

第9章 放射線治療市場：処置別

  • イントロダクション
  • 外部照射放射線治療
    • IMRT
    • IGRT
    • 3次元原体放射線治療
    • SRT
    • 粒子線治療
  • 内部照射放射線治療/近接照射療法
    • LDR近接照射療法
    • HDR近接照射療法
    • PDR近接照射療法
  • 全身性放射線治療
    • 静脈内放射線治療
    • 経口放射線治療
    • 点滴放射線治療

第10章 放射線治療市場：エンドユーザー別

  • イントロダクション
  • 病院
  • 独立の放射線治療センター

第11章 放射線治療市場：地域別

  • イントロダクション
  • 北米
    • 北米の不況の影響
    • 米国
    • カナダ
  • 欧州
    • 欧州の不況の影響
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋
    • アジア太平洋の不況の影響
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ラテンアメリカの不況の影響
    • ブラジル
    • メキシコ
    • その他のラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 概要
  • 主要企業戦略/有力企業
  • 収益分析
  • 市場シェア分析
  • 企業の評価マトリクス
  • スタートアップ/中小企業の評価マトリクス
  • 競合シナリオと動向

第13章 企業プロファイル

  • 主要企業
    • SIEMENS HEALTHINEERS GMBH (VARIAN MEDICAL SYSTEMS, INC.)
    • ELEKTA
    • ACCURAY INCORPORATED
    • IBA WORLDWIDE (ION BEAM APPLICATIONS SA)
    • VIEWRAY TECHNOLOGIES, INC.
    • PERSPECTIVE THERAPEUTICS, INC.
    • HITACHI LTD.
    • SUMITOMO HEAVY INDUSTRIES LTD.
    • CARL ZEISS MEDITEC AG
    • MIM SOFTWARE INC.
    • PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
    • PROVISION HEALTHCARE
    • MEVION MEDICAL SYSTEMS
    • OPTIVUS PROTON THERAPY, INC.
    • P-CURE
    • INTRAOP MEDICAL, INC.
    • BEBIG MEDICAL
    • KONINKLIJKE PHILIPS N.V.
    • RAYSEARCH LABORATORIES
    • THERAGENICS
  • その他の企業
    • PROTOM INTERNATIONAL
    • DOSISOFT SA
    • ISOAID
    • MAGNETTX ONCOLOGY SOLUTIONS LTD.
    • BRAINLAB AG

第14章 付録

目次
Product Code: MD 1773

Report Description

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsType, Technology, Application, Procedure, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

The global radiotherapy market is projected to reach USD 8.8 billion by 2028 from USD 6.9 billion in 2023, growing at a CAGR of 5.0% during the forecast period. The rising incidence of cancer worldwide, advancements in radiotherapy treatment technologies, and growing adoption of particle therapy among cancer centers globally are likely to support the growth of radiotherapy market during the forecast period.

" Software & Services segment of global radiotherapy market to grow with the highest CAGR in the forecast period."

Based on type, the radiotherapy market is segmented into products and software & services. The software & service segment is expected to register a higher growth rate majorly in well-established market such as North America and Europe. The ongoing advancements in radiotherapy and increasing demand for more precise, and personalized cancer care treatment plan are leading towards the development of innovative radiotherapy softwares & services.

" External Beam Radiotherapy segment, by technology , accounted for the largest market share of global radiotherapy system market in 2022."

Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy. The external beam radiotherapy (EBRT) segment accounted for the largest share of radiotherapy in 2022, owing to widespread adoption external beam radiotherapy technology and continuous investment in R&D by market players for development and commercializing advanced external beam radiotherapy technologies.

" Prostate cancer, by external beam radiotherapy application , accounted for the largest market share of in 2022."

Based on application, the radiotherapy market is classified into two major segments-external beam radiotherapy and internal beam radiotherapy/brachytherapy applications.

The external beam radiotherapy applications segment is further segmeneted into breast, prostate cancer, head and neck cancer, lung cancer, colorectla cancer and other cancer

The internal beam radiotherapy/brachytherapy applications segment is further divided into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers (lung cancer and head and neck cancers).

Prostate cancer accounted for the largest market share in 2022 owing to the increasing incidence of prostate cancer globally, advantages offered by external beam radiotherapy treatment for prostate cancer, and increase in research activities in the field of radiation therapy for prostate cancer treatment

North America accounted for the largest share of the radiotherapy market by region.

The global radiotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for radiotherapy products and services , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of advanced radiotherapy technologies, increases collaboration among radiotherapy software manufacturers and end users, presence of diverse network of healthcare facilities and services across countries of North America , and favorable reimbursement models supporting cancer care in the region

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
  • By Designation: C-level-10%, Director-level-14%, and Others-76%
  • By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, MEA- 3%

The prominent players in the radiotherapy market are Siemens Healthcare GmbH (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), C-RAD (Sweden), IBA Worldwide (Belgium), Hitachi Ltd. (Japan (US), Mevion Medical Systems (US), Optivus Proton Therapy, Inc. (US) and Panacea Medical Technologies Pvt. Ltd. (India), among others.

Research Coverage

This report studies the radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

This report provides insights on the following pointers:

  • Analysis of key drivers (technological advancements, rising prevalence of cancer, growing use of particle therapy), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries), and challenges (risk of radiation exposure) influencing the growth of radiotherapy market
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the radiotherapy market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapy market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the radiotherapy market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 REGIONS COVERED
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 KEY STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
  • 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY RESEARCH
      • 2.1.2.1 Key data from primary sources
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 GLOBAL RADIOTHERAPY MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL RADIOTHERAPY MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.4.1 RESEARCH ASSUMPTIONS
    • 2.4.2 RESEARCH LIMITATIONS
  • 2.5 RECESSION IMPACT ANALYSIS
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)

3 EXECUTIVE SUMMARY

    • FIGURE 7 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2023 VS. 2028
    • FIGURE 11 RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 RADIOTHERAPY MARKET OVERVIEW
    • FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH
  • 4.2 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • 4.3 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2022)
    • FIGURE 13 LINACS HELD LARGEST SHARE IN 2O22
  • 4.4 RADIOTHERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 14 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Advancements in radiotherapy treatment technology
      • 5.2.1.2 Growing patient population
    • FIGURE 16 PROJECTED INCREASE IN CANCER CASES, 2020-2040
      • 5.2.1.3 Increasing initiatives to promote radiotherapy awareness
      • 5.2.1.4 Growing use of particle therapy for cancer treatment
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of adequate healthcare infrastructure
      • 5.2.2.2 High capital cost of radiotherapy
      • 5.2.2.3 Complexity of radiotherapy
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging economies
      • 5.2.3.2 Favorable changes in US radiotherapy payment model
      • 5.2.3.3 Government and private investments to meet rising demand for cancer treatment
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled personnel
      • 5.2.4.2 Difficulties in visualizing tumors during radiotherapy
      • 5.2.4.3 Risk of radiation exposure
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 2 RADIOTHERAPY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 DEGREE OF COMPETITION
  • 5.4 REGULATORY LANDSCAPE
    • TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
    • TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.4.2 CANADA
    • TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
    • 5.4.3 EUROPE
    • 5.4.4 ASIA PACIFIC
      • 5.4.4.1 China
      • 5.4.4.2 Japan
    • TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    • 5.4.5 INDIA
  • 5.5 REIMBURSEMENT SCENARIO
    • TABLE 9 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES
    • TABLE 10 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS 2022
    • TABLE 11 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
    • TABLE 12 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
  • 5.6 ECOSYSTEM/MARKET MAP
  • 5.7 VALUE CHAIN ANALYSIS
    • 5.7.1 RESEARCH & DEVELOPMENT
    • 5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT
    • 5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
    • FIGURE 17 VALUE CHAIN ANALYSIS
  • 5.8 SUPPLY CHAIN ANALYSIS
    • 5.8.1 PROMINENT COMPANIES
    • 5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
    • 5.8.3 END USERS
    • FIGURE 18 SUPPLY CHAIN ANALYSIS
  • 5.9 TRADE DATA
    • TABLE 13 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017-2021 (USD MILLION)
    • TABLE 14 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017-2021 (USD MILLION)
  • 5.10 PRICING ANALYSIS
    • FIGURE 19 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS
    • TABLE 15 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD)
    • TABLE 16 AVERAGE SELLING PRICE TRENDS
  • 5.11 KEY CONFERENCES & EVENTS IN 2023-2025
    • TABLE 17 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 PATENT ANALYSIS
    • FIGURE 20 TOP PATENT APPLICANTS FOR PROTON BEAM THERAPY, JANUARY 2012-OCTOBER 2023
    • FIGURE 21 TOP PATENT APPLICANTS FOR MEDICAL LINEAR ACCELERATORS, JANUARY 2012-OCTOBER 2023
  • 5.14 CASE STUDY ANALYSIS
    • TABLE 18 CASE STUDY: ENHANCING PATIENT SAFETY-SBRT'S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC)
  • 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 22 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
    • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES
    • 5.16.2 BUYING CRITERIA
    • FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY
    • TABLE 20 KEY BUYING CRITERIA FOR RADIOTHERAPY

6 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 21 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2022-2028 (USD MILLION)
  • 6.2 PRODUCTS
    • 6.2.1 CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET
    • TABLE 22 RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 6.3 SOFTWARE & SERVICES
    • 6.3.1 INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH
    • TABLE 23 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022-2028 (USD MILLION)

7 RADIOTHERAPY MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 24 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
  • 7.2 EXTERNAL BEAM RADIOTHERAPY
    • TABLE 25 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 26 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 LINACS
    • TABLE 27 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 28 LINACS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.1 CONVENTIONAL LINACS
      • 7.3.1.1 Long treatment duration to limit adoption
    • TABLE 29 CONVENTIONAL LINACS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.2 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
    • TABLE 30 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 31 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 7.3.2.1 CyberKnife
        • 7.3.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market
    • TABLE 32 CYBERKNIFE MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 7.3.2.2 Gamma Knife
        • 7.3.2.2.1 Ongoing product development and launches to support growth
    • TABLE 33 GAMMA KNIFE MARKET, BY REGION, 2021-2028 (USD MILLION)
      • 7.3.2.3 TomoTherapy
        • 7.3.2.3.1 High installation and maintenance costs to limit adoption
    • TABLE 34 TOMOTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.3.3 MRI LINACS
      • 7.3.3.1 Real-time imaging advantage to propel growth
    • TABLE 35 MRI LINACS MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 7.4 PARTICLE THERAPY
    • TABLE 36 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2021-2028 (USD MILLION)
    • TABLE 37 PARTICLE THERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.1 CYCLOTRONS
      • 7.4.1.1 Enhanced outcomes and other advantages to boost adoption
    • TABLE 38 CYCLOTRONS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.2 SYNCHROTRONS
      • 7.4.2.1 Increasing investments in synchrotron facilities to drive market
    • TABLE 39 SYNCHROTRONS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 7.4.3 SYNCHROCYCLOTRONS
      • 7.4.3.1 High space requirements limit widespread adoption
    • TABLE 40 SYNCHROCYCLOTRONS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.5 CONVENTIONAL COBALT-60 TELETHERAPY
    • 7.5.1 COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION
    • TABLE 41 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.6 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    • TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.7 SEEDS
    • 7.7.1 ADVERSE SIDE-EFFECTS ASSOCIATED WITH SEEDS TO LIMIT ADOPTION
    • TABLE 44 SEEDS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.8 AFTERLOADERS
    • 7.8.1 PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND
    • TABLE 45 AFTERLOADERS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.9 IORT SYSTEMS
    • 7.9.1 RISING ADOPTION OF ELECTRONIC BRACHYTHERAPY PROCEDURES TO SUPPORT GROWTH
    • TABLE 46 IORT SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.10 APPLICATORS
    • 7.10.1 HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH
    • TABLE 47 APPLICATORS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.11 SYSTEMIC RADIOTHERAPY
    • 7.11.1 HIGH RISK OF RADIATION EXPOSURE TO LIMIT ADOPTION
    • 7.11.2 IOBENGUANE (I-131)
    • 7.11.3 SAMARIUM-153
    • 7.11.4 RHENIUM-186
    • 7.11.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS

8 RADIOTHERAPY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 48 RADIOTHERAPY MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
    • TABLE 49 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 50 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022-2028 (USD MILLION)
    • 8.2.1 PROSTATE CANCER
      • 8.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth
    • TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 BREAST CANCER
      • 8.2.2.1 Therapeutic benefits of EBRT to drive market
    • TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 LUNG CANCER
      • 8.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market
    • TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.4 HEAD & NECK CANCER
      • 8.2.4.1 Noninvasive treatment of head & neck cancers to drive market
    • TABLE 54 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.5 COLORECTAL CANCER
      • 8.2.5.1 High incidence of colorectal cancer to support market growth
    • TABLE 55 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.6 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
    • TABLE 56 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
    • TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.1 PROSTATE CANCER
      • 8.3.1.1 Precision of brachytherapy to drive market
    • TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2022-2028 (USD MILLION)
    • 8.3.2 GYNECOLOGICAL CANCER
      • 8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy
    • TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 BREAST CANCER
      • 8.3.3.1 Wide usage as replacement for traditional EBRT to drive market
    • TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.4 CERVICAL CANCER
      • 8.3.4.1 Effectiveness of combined brachytherapy-chemotherapy procedure to support adoption
    • TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.5 PENILE CANCER
      • 8.3.5.1 Rising awareness and effectiveness of brachytherapy to drive market
    • TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.6 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
    • TABLE 64 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021-2028 (USD MILLION)

9 RADIOTHERAPY MARKET, BY PROCEDURE

  • 9.1 INTRODUCTION
    • TABLE 65 RADIOTHERAPY MARKET, BY PROCEDURE, 2022-2028 (USD MILLION)
  • 9.2 EXTERNAL BEAM RADIOTHERAPY
    • TABLE 66 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.2.1 IMRT
      • 9.2.1.1 Advantages over 2D and 3D-CRT to boost adoption
    • TABLE 68 IMRT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.2.2 IGRT
      • 9.2.2.1 Growing demand in treating deep-seated tumors to drive market
    • TABLE 69 IGRT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.2.3 3D CONFORMAL RADIOTHERAPY
      • 9.2.3.1 High precision and minimized damage to nearby tissues to boost adoption
    • TABLE 70 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.2.4 SRT
      • 9.2.4.1 Minimally invasive procedure to drive end-user preference
    • TABLE 71 SRT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.2.5 PARTICLE THERAPY
      • 9.2.5.1 High usage as primary mode of cancer treatment to sustain market growth
    • TABLE 72 PARTICLE THERAPY MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
    • TABLE 73 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 74 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.3.1 LDR BRACHYTHERAPY
      • 9.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption
    • TABLE 75 LDR BRACHYTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.3.2 HDR BRACHYTHERAPY
      • 9.3.2.1 Possibility of tissue injury to affect adoption
    • TABLE 76 HDR BRACHYTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 9.3.3 PDR BRACHYTHERAPY
      • 9.3.3.1 Combination of advantages to boost growth
    • TABLE 77 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.4 SYSTEMIC RADIOTHERAPY
    • 9.4.1 HIGH COST OF RADIOPHARMACEUTICALS AND RISK OF RADIATION EXPOSURE TO LIMIT USAGE
    • 9.4.2 INTRAVENOUS RADIOTHERAPY
    • 9.4.3 ORAL RADIOTHERAPY
    • 9.4.4 INSTILLATION RADIOTHERAPY

10 RADIOTHERAPY MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 78 RADIOTHERAPY MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS
    • 10.2.1 HOSPITALS TO DOMINATE END-USER MARKET
    • TABLE 79 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021-2028 (USD MILLION)
  • 10.3 INDEPENDENT RADIOTHERAPY CENTERS
    • 10.3.1 LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH
    • TABLE 80 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021-2028 (USD MILLION)

11 RADIOTHERAPY MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 81 RADIOTHERAPY MARKET, BY REGION, 2022-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 25 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
    • TABLE 82 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 84 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 85 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 90 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 Changes in reimbursement scenario to drive market growth
    • TABLE 92 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 93 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 94 US: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 95 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing prevalence of cancer to drive demand for radiotherapy
    • TABLE 96 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 97 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 98 CANADA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 99 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 101 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 102 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 103 EUROPE: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 104 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 105 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022-2028 (USD MILLION)
    • TABLE 106 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • TABLE 107 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 108 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Availability of novel radiotherapy products to drive market
    • TABLE 110 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 111 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 112 GERMANY: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 113 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 High purchasing & maintenance costs of advanced radiotherapy systems to limit market growth
    • TABLE 114 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 115 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 116 FRANCE: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 117 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.3.4 UK
      • 11.3.4.1 High healthcare expenditure to drive market
    • TABLE 118 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 119 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 120 UK: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 121 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Growing research activities on cancer care drive market
    • TABLE 122 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 123 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 124 SPAIN: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 125 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.3.6 ITALY
      • 11.3.6.1 High number of oncology-specific clinical trials & studies to support market growth
    • TABLE 126 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 127 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 128 ITALY: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 129 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 130 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 131 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 132 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 133 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 26 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
    • TABLE 134 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022-2028 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • TABLE 141 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 142 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 143 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Rising geriatric population and cancer incidence to drive market
    • TABLE 144 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 145 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 146 JAPAN: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 147 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Growing partnerships among market players to support growth
    • TABLE 148 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 149 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 150 CHINA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 151 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 High need for radiotherapy systems to provide opportunities
    • TABLE 152 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 153 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 154 INDIA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 155 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Increasing incidence of cancer to support market
    • TABLE 156 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 157 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 158 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 159 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.4.6 AUSTRALIA
      • 11.4.6.1 Availability of funding for cancer care & research to drive growth
    • TABLE 160 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 161 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 162 AUSTRALIA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 163 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.4.7 REST OF ASIA PACIFIC
    • TABLE 164 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 165 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 166 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 167 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 168 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022-2028 (USD MILLION)
    • TABLE 169 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 170 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 171 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 172 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 173 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022-2028 (USD MILLION)
    • TABLE 174 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2023-2028 (USD MILLION)
    • TABLE 175 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 176 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 177 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022-2028 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 Restricted affordability & access to radiotherapy to challenge market growth
    • TABLE 178 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 179 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 180 BRAZIL: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 181 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.5.3 MEXICO
      • 11.5.3.1 Rising target population to boost market growth
    • TABLE 182 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 183 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 184 MEXICO: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 185 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 186 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 187 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 188 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 189 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET
    • 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 190 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022-2028 (USD MILLION)
    • TABLE 191 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 192 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 193 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 194 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022-2028 (USD MILLION)
    • TABLE 195 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022-2028 (USD MILLION)
    • TABLE 196 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 197 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022-2028 (USD MILLION)
    • TABLE 198 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022-2028 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY KEY RADIOTHERAPY PLAYERS (2020 TO 2023)
  • 12.3 REVENUE ANALYSIS
    • FIGURE 28 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019-2022
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 29 RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
  • 12.5 COMPANY EVALUATION MATRIX
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 30 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022
    • 12.5.5 COMPANY FOOTPRINT
    • TABLE 199 PRODUCT FOOTPRINT (18 COMPANIES)
    • TABLE 200 REGIONAL FOOTPRINT (18 COMPANIES)
    • TABLE 201 COMPANY FOOTPRINT (18 COMPANIES)
  • 12.6 START-UP/SME EVALUATION MATRIX
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • FIGURE 31 RADIOTHERAPY MARKET: START-UP/SME EVALUATION MATRIX, 2022
    • 12.6.5 COMPETITIVE BENCHMARKING
    • TABLE 202 RADIOTHERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 12.7 COMPETITIVE SCENARIO AND TRENDS
    • 12.7.1 PRODUCT LAUNCHES & APPROVALS
    • 12.7.2 DEALS
    • 12.7.3 OTHER DEVELOPMENTS

13 COMPANY PROFILES

(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)**

  • 13.1 KEY PLAYERS
    • 13.1.1 SIEMENS HEALTHINEERS GMBH (VARIAN MEDICAL SYSTEMS, INC.)
    • TABLE 203 SIEMENS HEALTHINEERS GMBH: COMPANY OVERVIEW
    • FIGURE 32 SIEMENS HEALTHINEERS GMBH: COMPANY SNAPSHOT (2022)
    • 13.1.2 ELEKTA
    • TABLE 204 ELEKTA: COMPANY OVERVIEW
    • FIGURE 33 ELEKTA: COMPANY SNAPSHOT (2022)
    • 13.1.3 ACCURAY INCORPORATED
    • TABLE 205 ACCURAY INCORPORATED: COMPANY OVERVIEW
    • FIGURE 34 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2023)
    • 13.1.4 IBA WORLDWIDE (ION BEAM APPLICATIONS SA)
    • TABLE 206 IBA WORLDWIDE: COMPANY OVERVIEW
    • FIGURE 35 IBA WORLDWIDE: COMPANY SNAPSHOT (FY 2022)
    • 13.1.5 VIEWRAY TECHNOLOGIES, INC.
    • TABLE 207 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW
    • FIGURE 36 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (FY 2022)
    • 13.1.6 PERSPECTIVE THERAPEUTICS, INC.
    • TABLE 208 PERSPECTIVE THERAPEUTICS, INC.: COMPANY OVERVIEW
    • FIGURE 37 PERSPECTIVE THERAPEUTICS, INC.: COMPANY SNAPSHOT (FY 2022)
    • 13.1.7 HITACHI LTD.
    • TABLE 209 HITACHI LTD.: COMPANY OVERVIEW
    • FIGURE 38 HITACHI LTD.: COMPANY SNAPSHOT (FY 2022)
    • 13.1.8 SUMITOMO HEAVY INDUSTRIES LTD.
    • TABLE 210 SUMITOMO HEAVY INDUSTRIES LTD.: COMPANY OVERVIEW
    • FIGURE 39 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (FY 2022)
    • 13.1.9 CARL ZEISS MEDITEC AG
    • TABLE 211 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW
    • FIGURE 40 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
    • 13.1.10 MIM SOFTWARE INC.
    • TABLE 212 MIM SOFTWARE INC.: COMPANY OVERVIEW
    • 13.1.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
    • TABLE 213 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
    • 13.1.12 PROVISION HEALTHCARE
    • TABLE 214 PROVISION HEALTHCARE: COMPANY OVERVIEW
    • 13.1.13 MEVION MEDICAL SYSTEMS
    • TABLE 215 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
    • 13.1.14 OPTIVUS PROTON THERAPY, INC.
    • TABLE 216 OPTIVUS PROTON THERAPY: COMPANY OVERVIEW
    • 13.1.15 P-CURE
    • TABLE 217 P-CURE: COMPANY OVERVIEW
    • 13.1.16 INTRAOP MEDICAL, INC.
    • TABLE 218 INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
    • 13.1.17 BEBIG MEDICAL
    • TABLE 219 BEBIG MEDICAL: COMPANY OVERVIEW
    • 13.1.18 KONINKLIJKE PHILIPS N.V.
    • TABLE 220 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
    • FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 13.1.19 RAYSEARCH LABORATORIES
    • TABLE 221 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
    • FIGURE 42 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
    • 13.1.20 THERAGENICS
    • TABLE 222 THERAGENICS CORPORATION: COMPANY OVERVIEW
  • 13.2 OTHER PLAYERS
    • 13.2.1 PROTOM INTERNATIONAL
    • 13.2.2 DOSISOFT SA
    • 13.2.3 ISOAID
    • 13.2.4 MAGNETTX ONCOLOGY SOLUTIONS LTD.
    • 13.2.5 BRAINLAB AG
  • *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS